Zoetis (ZTS) Capital Expenditures (2012 - 2026)

Zoetis (ZTS) reported Capital Expenditures of $110.0 million for Q1 2026, up 3566.67% year-over-year from $3.0 million in Q1 2025, and up 124.12% quarter-over-quarter from -$456.0 million in Q4 2025.

Zoetis (ZTS) Capital Expenditures (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has 15 years of Capital Expenditures data on file, last reported at $110.0 million in Q1 2026.

  • Capital Expenditures for Q1 2026 came in at $110.0 million, up 3566.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $111.0 million (up 182.84% YoY), and the FY2025 annual result was $4.0 million, up 33.33% from the prior year.
  • Capital Expenditures rose to $110.0 million in Q1 2026 per ZTS's latest filing, from -$456.0 million in the prior quarter.
  • Over five years, Capital Expenditures peaked at $457.0 million in Q3 2025 and troughed at -$456.0 million in Q4 2025.
  • A 5-year average of $7.6 million and a median of $3.0 million in 2023 frame the typical range for Capital Expenditures.
  • The sharpest annual moves came in 2024 and 2025: Capital Expenditures soared 4566.67% in 2024, then slumped 45500.0% in 2025.
  • A 5-year view of Capital Expenditures shows it stood at -$2.0 million in 2022, then changed by 0.0% to -$2.0 million in 2023, then soared by 50.0% to -$1.0 million in 2024, then tumbled by 45500.0% to -$456.0 million in 2025, then jumped by 124.12% to $110.0 million in 2026.
  • Business Quant data shows ZTS's Capital Expenditures at $110.0 million in Q1 2026, -$456.0 million in Q4 2025, and $457.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 168.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 110.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 100.80 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 9.10 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 51.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 4.09 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 2.04 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 8.83 Mn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn 6.59 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 110.00 Mn
Mar 31, 2026 110.00 Mn
Dec 31, 2025 -456.00 Mn
Dec 31, 2025 -456.00 Mn
Sep 30, 2025 457.00 Mn
Sep 30, 2025 457.00 Mn
Mar 31, 2025 3.00 Mn
Mar 31, 2025 3.00 Mn
Dec 31, 2024 -1.00 Mn
Dec 31, 2024 -1.00 Mn
Sep 30, 2024 -268.00 Mn
Sep 30, 2024 -268.00 Mn
Jun 30, 2024 132.00 Mn
Jun 30, 2024 132.00 Mn
Mar 31, 2024 140.00 Mn
Mar 31, 2024 140.00 Mn
Dec 31, 2023 -2.00 Mn
Dec 31, 2023 -2.00 Mn
Sep 30, 2023 -385.00 Mn
Sep 30, 2023 -385.00 Mn